WHERE REGULATORY LEADERSHIP MEETS SCIENTIFIC INSIGHT
RCSS is an independent regulatory consultancy led by Dr. Nathalie Machluf, a former VP of Regulatory Affairs with extensive experience in global drug development across biological and pharmaceutical products.
RCSS provides executive-level regulatory leadership across CMC, clinical, and submission strategy, supporting biotech and pharmaceutical companies throughout the full product lifecycle — from early clinical development through global registration and post-approval.
By combining deep scientific expertise with strategic regulatory leadership, RCSS helps companies navigate complex regulatory pathways with clarity, mitigate development risks, and advance innovative products efficiently and successfully.
WHY WORK WITH RCSS
-
Executive-Level Expertise: Direct access to a former VP of Regulatory Affairs with global experience in biologics and pharmaceuticals.
-
Strategic Guidance Across the Lifecycle: From early clinical development to post-approval, RCSS provides leadership in regulatory, CMC, non-clinical, clinical and submission strategy.
-
Risk Mitigation & Efficiency: Navigate complex regulatory pathways with clarity, avoid common pitfalls, and accelerate product development.
-
Tailored, High-Impact Support: Hands-on involvement in critical submissions, reviews, and strategic decision-making whenever needed.
ONE GOAL
YOUR SUCCESS
Every milestone brings us closer to delivering innovative treatments to the patients who need them most.
As a passionate scientist, I’m deeply driven by the impact of innovation in healthcare. I bring that commitment into every project, mindful of time, budget, and resource constraints.
VISION TO DRIVE SUCCESS
1- Successful drug development hinges on the seamless integration of scientific insight, strategic foresight, and regulatory fluency.
When science and regulation are aligned from the outset, decision-making becomes more efficient, risks are minimized, and access to transformative therapies is accelerated.
2- A smooth review process depends on the ability to submit clear, accessible documentation that effectively conveys complex scientific data.
By assembling the scientific puzzle in a clear and comprehensive manner that instills confidence in regulators, the submission minimizes regulatory obstacles and fosters trust with the sponsor, which is a fundamental element required to secure clinical development and approval.